Clinical Trials Directory

Trials / Conditions / Pembrolizumab

Pembrolizumab

14 registered clinical trials studyying Pembrolizumab — 6 currently recruiting.

StatusTrialSponsorPhase
RecruitingPhase 2 Trial of Zanzalintinib and Pembrolizumab in Select Subtypes of Advanced/Metastatic Soft-tissue Sarcoma
NCT07283731
M.D. Anderson Cancer CenterPhase 2
Not Yet RecruitingNeoadjuvant Immunotherapy and Organ-sparing Treatment in Patients With Stage I-III dMMR Colon Cancer
NCT07409844
Ismail GögenurPhase 2
RecruitingPhase II Study of Weekly Paclitaxel/Nab-Paclitaxel, Pembrolizumab, and Mirabegron for Recurrent Ovarian Cancer
NCT07261683
Obstetrics & Gynecology Hospital of Fudan UniversityPhase 2
RecruitingPhase II Study of Moderate-dose Hypofractionated RT Combined With Pembrolizumab for HCC With Diffuse Tumor Thr
NCT06389422
Cancer Institute and Hospital, Chinese Academy of Medical SciencesPhase 2
RecruitingEvaluating the Efficacy and Safety of Pembrolizumab Plus Standard Chemotherapy in the Neoadjuvant Treatment of
NCT06102395
Beijing Tongren HospitalPhase 3
UnknownImpact of Immuno-Oncologic Agent on Neoadjuvant Chemotherapy in Triple Negative Breast Cancer
NCT05910710
Samsung Medical Center—
Not Yet RecruitingPhase Ib/II Trial of Combining Pembrolizumab and Lenvatinib With SBRT for HCC Patients With Portal Vein Thromb
NCT05286320
National Taiwan University HospitalPhase 1 / Phase 2
Active Not RecruitingThe Study Collect Clinical Data From the Treatment of Liver Cancer With New Drugs After 2019 and Integrate Bio
NCT07233759
National Taiwan University Hospital—
TerminatedSitravatinib Plus Pembrolizumab in Patients With Advanced Treatment-Naïve PD-L1+ Non-Squamous NSCLC
NCT04925986
Sarah GoldbergPhase 2
TerminatedPembrolizumab and Lenvatinib in Patients With Brain Metastases From Melanoma or Renal Cell Carcinoma
NCT04955743
Yale UniversityPhase 2
UnknownPembrolizumab in Post Radical Operation ESCC Patients With Lymph Node Positive ( KEYSTONE-004 )
NCT04863079
Tianjin Medical University Cancer Institute and HospitalPhase 2
UnknownA Study With Pembrolizumab for Non-small Cell Lung Cancer (NSCLC)
NCT04393883
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityN/A
UnknownPembrolizumab Plus Neoadjuvant Chemotherapy for Locally Advanced EGJ Adenocarcinoma
NCT04813523
Tianjin Medical University Cancer Institute and HospitalPhase 2
UnknownAnalysis of Gut Microbiota in Patients With Brain Metastasis of Non-small Cell Lung Cancer Treated by Pembroli
NCT04333004
Xiaorong DongPhase 1 / Phase 2